Ravi Doobay, MD, FRCPC Ravi Doobay, MD, FRCPC

Ravi Doobay

MD, FRCPC
Critical Care Medicine

Special Interests:

End of life discussions Factors that adversely impact surrogate decision making Cost-Effectiveness in the ICU Re-intubation rates in the ICU

About Ravi Doobay

Positions

Roswell Park Comprehensive Cancer Center

  • Assistant Professor of Critical Care Medicine & Oncology
  • Department of Critical Care Medicine

Background

Education and Training:

  • 2015 - MD - SABA University School of Medicine, The Bottom, Netherland-Antilles

Residency:

  • 2018-2019 - Chief Medical Resident, SUNY Upstate Medical University, Syracuse, NY
  • 2015-2018 - Internal Medicine Resident, SUNY Upstate Medical University, Syracuse, NY

Fellowship:

  • 2019-2021 - Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA

Board Certification:

  • American Board of Internal Medicine
  • Fellow of the Royal College of Physicians Canada (Internal Medicine)

Professional Memberships:

  • Society of Critical Care Medicine

Professional Experience:

  • Staff Intensivist at Roswell Park Comprehensive Cancer Center

Honors & Awards:

  • 2018 - Inducted into Alpha Omega Alpha Honors Society

Publications

1) Munshi L, Kobayashi T, DeBacker J, Doobay R, Telesnicki T, Lo V, Cote N, Cypel M, Keshavjee S, Ferguson ND, Fan E. Intensive Care Physiotherapy during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. Annals of the American Thoracic Society. 2017 Feb;14(2):246-253. PMID: 27898220

2) Doobay R, Sun L, Shah A, Masuta P, Shepherd Z. SSRI Facilitated Crack Dancing. Case Reports in Neurological Medicine. 2017 April 11; PMID: 28487792

3) Doobay R, Gambhir HS. Cardiac Tamponade Induced by Tacrolimus Toxicity. American Journal of Therapeutics. 2017 June 26; PMID: 28708698

4) Doobay R, Shah A, Landsberg D. 1.25% saline solution for septic patients with active stroke. American Journal of Therapeutics. 2017 October 2; PMID: 28991870

5) Jessamy K, Ojevwe FO, Doobay R, Naous R, Yu J, Lemke SM. Primary Effusion Lymphoma: Is Dose-Adjusted-EPOCH Worthwhile Therapy? Case Reports in Oncology. 2016 May 23;9 (1):273-279. PMID: 27462227